Heel at Neuroscience 2011: Research Supports Multitarget Approach to Alzheimer’s

WASHINGTON, DC & BADEN-BADEN, Germany--(BUSINESS WIRE)--The Neuroscience convention in Washington is the premier venue for neuroscientists from around the world to debate cutting-edge research on the nervous system. More than 36,000 attendees came together in Washington DC from November 12-16, 2011. Here, Heel presented latest studies on a multitarget medication based on low dose natural substances that has proven to positively influence both symptoms as well as disease-related mechanisms of Alzheimer’s.

MORE ON THIS TOPIC